[ORGANIZATION]
Genasys
Featured in 2 tracked stories · first seen
Situations
Humacyte clinical trial and financial updates
2 clusters · 6 sources · last updated
Latest: Corporate earnings reports released for multiple sectors
Humacyte reported its second quarter 2026 financial results alongside positive interim data from its V012 Phase 3 trial. The trial, which utilized acellular tissue engineered vessels (ATEV) in female dialysis patients, d
Also covered in
-
Genasys and GDS report divergent quarterly earnings results
[BUSINESS] · 2 sources ·